InvestSMART

Bioxyne Limited (ASX: BXN) - Announcements

Current share price for BXN : $0.930 0.01 (1.06%)+

ASX company news and announcements for Bioxyne Limited (BXN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bioxyne Limited (BXN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bioxyne Limited (BXN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bioxyne Limited (BXN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$214 BXN Ships Australian Made MDMA to Vic Gov Hospital Trial 26 Nov 2025 8:28AM $0.036 $0.930 risen by 2,483.33%
$214 Funding from SOSE to Establish UK GMP Manufacturing Facility 17 Nov 2025 8:25AM $0.039 $0.930 risen by 2,284.62%
$214 BXN Releases Australian Made GMP MDMA 11 Nov 2025 8:23AM $0.040 $0.930 risen by 2,225%
$214 BLS to Manufacture and Distribute Curaleaf International MID 3 Nov 2025 8:29AM $0.040 $0.930 risen by 2,225%
$214 Presentation on FY2025 Quarter 1 Results 30 Oct 2025 11:46AM $0.040 $0.930 risen by 2,225%
$214 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2025 8:31AM $0.041 $0.930 risen by 2,168.29%
$214 Letter to Shareholders re Annual General Meeting 27 Oct 2025 7:46PM $0.043 $0.930 risen by 2,062.79%
$214 Notice of Annual General Meeting/Proxy Form 27 Oct 2025 7:17PM $0.043 $0.930 risen by 2,062.79%
$214 Change of Director Interest Notice X 2 27 Oct 2025 7:10PM $0.043 $0.930 risen by 2,062.79%
$214 Application for quotation of securities - BXN 27 Oct 2025 7:05PM $0.043 $0.930 risen by 2,062.79%
$214 Bioxyne Lists on Frankfurt Stock Exchange 13 Oct 2025 9:43AM $0.037 $0.930 risen by 2,413.51%
$214 US Cannabis Regulatory Developments - Implications for BXN 1 Oct 2025 9:57AM $0.038 $0.930 risen by 2,347.37%
$214 Appendix 4G and Corporate Governance Statement 30 Sep 2025 1:48PM $0.038 $0.930 risen by 2,347.37%
$214 Annual Report to shareholders 30 Sep 2025 1:42PM $0.038 $0.930 risen by 2,347.37%
$214 Initial German Purchase Orders and Import Permits 15 Sep 2025 9:05AM $0.040 $0.930 risen by 2,225%
$214 FY 2025 Results Webinar 9.30am 1 September 2025 1 Sep 2025 8:22AM $0.050 $0.930 risen by 1,760%
$214 BXN Full Year 2026 Guidance 29 Aug 2025 12:36PM $0.057 $0.930 risen by 1,531.58%
$214 BXN Full Year 2026 Guidance 29 Aug 2025 12:36PM $0.057 $0.930 risen by 1,531.58%
$214 FY2025 Results Presentation 29 Aug 2025 12:00PM $0.056 $0.930 risen by 1,560.71%
$214 FY2025 Results Presentation 29 Aug 2025 12:00PM $0.056 $0.930 risen by 1,560.71%
$214 Preliminary Final Report 29 Aug 2025 11:57AM $0.056 $0.930 risen by 1,560.71%
$214 Preliminary Final Report 29 Aug 2025 11:57AM $0.056 $0.930 risen by 1,560.71%
$214 Statement of Claim 27 Aug 2025 8:41AM $0.057 $0.930 risen by 1,531.58%
$214 30 June 2025 Appendix 4C Revised 18 Aug 2025 7:15PM $0.053 $0.930 risen by 1,654.72%
$214 Cleansing Notice 11 Aug 2025 4:22PM $0.053 $0.930 risen by 1,654.72%

51 - 75 of 457 results

Page 3 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.